Please see our blog post from Canadian members of our research consortium on developments towards a Canadian national rare disease policy, its challenges, potentialities and continued need for social pharmaceutical innovation: https://www.socialpharmaceuticalinnovation.org/post/canada-2019-budget-finally-includes-rare-disease

We are happy to announce the launch of the discussion forum on/for Social Pharmaceutical Innovation! Our vision is that this will be a virtual place for various stakeholders in rare diseases and other unmet medical needs to exchange information about their alternative forms of pharmaceutical research and development that are doing things differently in terms of involving users, addressing vulnerable populations and unmet needs, as a well a innovation for not solely market-driven purposes. We invite interested parties to post here, and respond to the materials posted from our research consortium. This will be a moderated forum, so we expect the usual respect and appropriate on-line behavior. We look forward to hearing from you. In kind regards, Dr. Conor Douglas SPIN Project Leader